Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2019

Open Access 01-12-2019 | Malaria | Meeting report

A stakeholder workshop about modelled maps of key malaria indicator survey indicators in Madagascar

Authors: Rosalind E. Howes, Kaleem Hawa, Voahangy Fanomezana Andriamamonjy, Thierry Franchard, Raharizo Miarimbola, Sedera Aurélien Mioramalala, Jean Florent Rafamatanantsoa, Mirana Ando Mbolatiana Rahantamalala, Solo Harimalala Rajaobary, Hariniaina David Gaël Rajaonera, Andrianiaina Parfait Rakotonindrainy, Clairaut Rakotoson Andrianjatonavalona, Dina Ny Aina Liantsoa Randriamiarinjatovo, Faratiana Michèle Randrianasolo, Rado Malalatiana Ramasy Razafindratovo, Masiarivony Ravaoarimanga, Maurice Ye, Peter W. Gething, Cameron A. Taylor

Published in: Malaria Journal | Issue 1/2019

Login to get access

Abstract

The Demographic and Health Surveys (DHS) Program has supported three household Malaria Indicator Surveys (MIS) in Madagascar. The results of 13 key malaria indicators from these surveys have been mapped as continuous surfaces using model-based geostatistical methods. The opportunities and limitations of these mapped outputs were discussed during a workshop in Antananarivo, Madagascar in July 2018, attended by 15 representatives from various implementation, policy and research stakeholder institutions in Madagascar. Participants evaluated the findings from the maps, using these to develop figures and narratives to support their work in the control of malaria in Madagascar.
Literature
1.
2.
Institut National de la Statistique (INSTAT), Programme National de Lutte contre le Paludisme (PNLP), and ICF International. Madagascar Malaria Indicator Survey 2011 [Enquête sur les Indicateurs du Paludisme (EIPM)]. Calverton, MC, USA: INSTAT, PNLP, and ICF International. 2011.
3.
Institut National de la Statistique (INSTAT), Programme National de Lutte contre le Paludisme (PNLP), Institut Pasteur de Madagascar (IPM), and ICF International. Madagascar Malaria Indicator Survey 2013 [Enquête sur les Indicateurs du Paludisme (EIPM)]. Calverton, MC, USA: INSTAT, PNLP, IPM and ICF International. 2013.
4.
Institut National de la Statistique (INSTAT), Programme National de Lutte contre le Paludisme (PNLP), Institut Pasteur de Madagascar (IPM), and ICF International. Madagascar Malaria Indicator Survey 2016 [Enquête sur les Indicateurs du Paludisme (EIPM)]. Calverton, MC, USA: INSTAT, PNLP, IPM and ICF International. 2016.
5.
Howes RE, Mioramalala SA, Ramiranirina B, Franchard T, Rakotorahalahy AJ, Bisanzio D, et al. Contemporary epidemiological overview of malaria in Madagascar: operational utility of reported routine case data for malaria control planning. Malar J. 2016;15:502.CrossRef
6.
Kang SY, Battle KE, Gibson HS, Ratsimbasoa A, Randrianarivelojosia M, Ramboarina S, et al. Spatio-temporal mapping of Madagascar’s malaria indicator survey results to assess Plasmodium falciparum endemicity trends between 2011 and 2016. BMC Med. 2018;16:71.CrossRef
7.
Ihantamalala FA, Herbreteau V, Rakotoarimanana FMJ, Rakotondramanga JM, Cauchemez S, Rahoilijaona B, et al. Estimating sources and sinks of malaria parasites in Madagascar. Nat Commun. 2018;9:3897.CrossRef
8.
Burgert-Brucker CR, Dontamsetti T, Gething PW. The DHS program’s modeled surfaces spatial datasets. Stud Fam Plann. 2018;49:87–92.CrossRef
9.
Hay SI, Snow RW. The malaria atlas project: developing global maps of malaria risk. PLoS Med. 2006;3:e473.CrossRef
10.
11.
Pfeffer DA, Lucas TCD, May D, Harris J, Rozier J, Twohig KA, et al. malariaAtlas: an R interface to global malariometric data hosted by the malaria atlas project. Malar J. 2018;17:352.CrossRef
12.
Cohen JM, Le Menach A, Pothin E, Eisele TP, Gething PW, Eckhoff PA, et al. Mapping multiple components of malaria risk for improved targeting of elimination interventions. Malar J. 2017;16:459.CrossRef
13.
Drake TL, Lubell Y. Malaria and economic evaluation methods: challenges and opportunities. Appl Health Econ Health Policy. 2017;15:291–7.CrossRef
14.
Drake TL, Lubell Y, Kyaw SS, Devine A, Kyaw MP, Day NPJ, et al. Geographic resource allocation based on cost effectiveness: an application to malaria policy. Appl Health Econ Health Policy. 2017;15:299–306.CrossRef
15.
WHO. World malaria report 2018. Geneva: World Health Organization; 2018.
16.
Dalrymple U, Mappin B, Gething PW. Malaria mapping: understanding the global endemicity of falciparum and vivax malaria. BMC Med. 2015;13:140.CrossRef
17.
18.
National Malaria Control Programme of Madagascar. National strategic plan for malaria control in Madagascar 2018–2022. Progressive malaria elimination from Madagascar. 2017.
19.
20.
21.
22.
23.
24.
25.
Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med. 2011;8:e1001142.CrossRef
Metadata
Title
A stakeholder workshop about modelled maps of key malaria indicator survey indicators in Madagascar
Authors
Rosalind E. Howes
Kaleem Hawa
Voahangy Fanomezana Andriamamonjy
Thierry Franchard
Raharizo Miarimbola
Sedera Aurélien Mioramalala
Jean Florent Rafamatanantsoa
Mirana Ando Mbolatiana Rahantamalala
Solo Harimalala Rajaobary
Hariniaina David Gaël Rajaonera
Andrianiaina Parfait Rakotonindrainy
Clairaut Rakotoson Andrianjatonavalona
Dina Ny Aina Liantsoa Randriamiarinjatovo
Faratiana Michèle Randrianasolo
Rado Malalatiana Ramasy Razafindratovo
Masiarivony Ravaoarimanga
Maurice Ye
Peter W. Gething
Cameron A. Taylor
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Malaria
Published in
Malaria Journal / Issue 1/2019
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-019-2729-7

Other articles of this Issue 1/2019

Malaria Journal 1/2019 Go to the issue

Research

Repeated mosquito net distributions, improved treatment, and trends in malaria cases in sentinel health facilities in Papua New Guinea

Correction

Correction to: Frozen blood clots can be used for the diagnosis of distinct Plasmodium species in man and non-human primates from the Brazilian Atlantic Forest

Research

A global analysis of National Malaria Control Programme vector surveillance by elimination and control status in 2018

Research

Problem formulation for gene drive mosquitoes designed to reduce malaria transmission in Africa: results from four regional consultations 2016–2018

Case study

Role of malaria partners in malaria elimination in Armenia

Case report

A cluster of the first reported Plasmodium ovale spp. infections in Peru occuring among returning UN peace-keepers, a review of epidemiology, prevention and diagnostic challenges in nonendemic regions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits